BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  CytoSen Therapeutics Appoints CEO and Scientific Advisory Board

  CytoSen Therapeutics announced today the appointment of Jak Knowles, M.D. as CEO and five new members to the company’s scientific and medical advisory board.

  October 23, 2017

   · 

  5 min read
• Biotech Beach

  OncoSec Announces $7.1 Million Registered Direct Offering Priced at-the-Market

  OncoSec announced today that it has entered into definitive purchase agreements with certain accredited investors to purchase 5,270,934 shares of its common stock, at a purchase price per share of $1.34375 in a registered direct offering priced at the market.

  October 23, 2017

   · 

  5 min read
• Business

  Dynatronics Announces Strategic Alliance Partnership with Zimmer MedizinSysteme

  Dynatronics today announced that it has signed an exclusive distribution agreement for the United States with Zimmer for select therapy equipment.

  October 23, 2017

   · 

  3 min read
• Business

  Invacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results

  Invacare Corporation announces that it will release its financial results for the third quarter 2017, after the market closes on Tuesday, November 7, 2017.

  October 23, 2017

   · 

  2 min read
• Business

  Coherus BioSciences to Report Third Quarter 2017 Financial Results on November 6th

  Starting at 4:30 p.m. EDT, Coherus’ management will host a conference call to discuss the financial results and provide a general business update.

  October 23, 2017

   · 

  1 min read
• Pharm Country

  BeyondSpring Receives Two Grants in China to Further Develop Innovative Drug Pipeline

  BeyondSpring received one in August 2017 from the city government of Dalian, China, and received the other on Sept. 30, 2017, from the Dalian Economic Development Park.

  October 23, 2017

   · 

  4 min read
• Drug Development

  Nanobiotix Completes Patient Inclusion for Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma

  NANOBIOTIX announced that it has completed patient inclusion for the Phase II/III trial (Act.In.Sarc) of its lead product candidate, NBTXR3, in soft tissue sarcoma.

  October 23, 2017

   · 

  2 min read
• BioMidwest

  Hallstar’s New Photostabilizer, AvoBrite, Solves Customers’ Regulatory Challenges While Delivering Outstanding Photoprotection

  Building on two decades of photoprotection technology, Hallstar recently launched its latest innovation, AvoBrite.

  October 23, 2017

   · 

  2 min read
• Biotech Beach

  Regen BioPharma Begins Program to Determine the 3-Dimensional Crystal Structure of NR2F6

  Regen BioPharma and (OTCQB: RGBPP) has begun a program to determine the 3-dimensional structure of NR2F6 both with and without the Company’s proprietary small molecule drugs bound to it.

  October 23, 2017

   · 

  2 min read
• Genetown

  Publication in npj Vaccines Demonstrates CureVac’s RNActive Vaccine is Superior to Licensed Vaccines

  CureVac today announced the publication of a study in the peer-reviewed journal, Nature Partner Journals Vaccines, demonstrating that vaccines based on CureVac’s sequence optimized, chemically unmodified mRNA formulated in optimized LNPs are highly immunogenic and well tolerated.

  October 23, 2017

   · 

  3 min read